(2018) Cytarabine/etoposide/idarubicin. Reactions Weekly, 1692 (1) 124 doi:10.1007/s40278-018-42652-6
Reference Type | Journal (article/letter/editorial) | ||
---|---|---|---|
Title | Cytarabine/etoposide/idarubicin | ||
Journal | Reactions Weekly | ||
Year | 2018 (March) | Volume | 1692 |
Issue | 1 | ||
Publisher | Springer Science and Business Media LLC | ||
DOI | doi:10.1007/s40278-018-42652-6Search in ResearchGate | ||
Generate Citation Formats | |||
Mindat Ref. ID | 13364080 | Long-form Identifier | mindat:1:5:13364080:1 |
GUID | 0 | ||
Full Reference | (2018) Cytarabine/etoposide/idarubicin. Reactions Weekly, 1692 (1) 124 doi:10.1007/s40278-018-42652-6 | ||
Plain Text | (2018) Cytarabine/etoposide/idarubicin. Reactions Weekly, 1692 (1) 124 doi:10.1007/s40278-018-42652-6 | ||
In | (2018, March) Reactions Weekly Vol. 1692 (1) Springer Science and Business Media LLC |
See Also
These are possibly similar items as determined by title/reference text matching only.
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |